KCND3 and atrial fibrillation: Olesen et al. first identified a gain of function mutation (A545P) in KCND3 associated with AF in Danish populations, which led to reduce action potential duration in an atrial cell model, but the mechanism underlying the enlargement of the current amplitude by the A545P mutation remains unclear [23].